Physician profile
Michael E Bailey
NPI 1043264880
$1,148.39
in general payments reported to CMS, 2019-2025
8 companies · $415 in 2025
The $415 reported for 2025 was more than what 96% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2023: $331 · 2024: $269 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.11 | 2022-2025 | |
| Janssen Biotech, INC. | $293.15 | 2022-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $196.10 | 2023-2025 | Entyvio, Eohilia |
| Regeneron Healthcare Solutions, INC. | $56.64 | 2024-2025 | Dupixent |
| Intercept Pharmaceuticals, INC. | $51.97 | 2022-2024 | Ocaliva |
| Phathom Pharmaceuticals, INC. | $30.93 | 2025 | Voquezna |
| Boston Scientific Corporation | $24.02 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Qol Medical, LLC | $19.47 | 2025 | Sucraid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.